These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 632675)
21. [Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?]. Schwertz H; Müller-Werdan U; Prondzinsky R; Werdan K; Buerke M Dtsch Med Wochenschr; 2004 Sep; 129(37):1925-30. PubMed ID: 15372372 [TBL] [Abstract][Full Text] [Related]
22. Dopamine: new uses for an old drug. Dipalma JR Am Fam Physician; 1975 Apr; 11(4):149-51. PubMed ID: 1119364 [No Abstract] [Full Text] [Related]
23. [Use of a new sympathomimetic amine in cardiogenic shock: dopamine. Personal experience]. Dauri A; Colace F; Palmieri GF; Bellanca T Minerva Anestesiol; 1976 Jun; 42(6):445-50. PubMed ID: 958642 [No Abstract] [Full Text] [Related]
24. Dopamine-associated symmetric peripheral gangrene. Park JY; Kanzler M; Swetter SM Arch Dermatol; 1997 Feb; 133(2):247-9. PubMed ID: 9041849 [No Abstract] [Full Text] [Related]
25. [First experiences with the use of dopamine (hydroxytyramine) in cardiogenic shock]. Döring D; Fleischmann HJ; Heunisch K; Köhler H; Trenckmann H Z Gesamte Inn Med; 1971 Dec; 26(24):759-63. PubMed ID: 5152441 [No Abstract] [Full Text] [Related]
26. [Our experience with the treatment of cardiogenic shock in recent myocardial infarction with dopamine and sodium nitroprusside]. Korewicki J; Ostrzycki A; Opolski G Kardiol Pol; 1984; 27(5):345-51. PubMed ID: 6387246 [No Abstract] [Full Text] [Related]
31. [Long-term use of dopamine in shock in patients with massive thromboembolism of the pulmonary artery]. Parkhomenko AN; Sirenko IuN Vrach Delo; 1989 Mar; (3):43-5. PubMed ID: 2750118 [No Abstract] [Full Text] [Related]
32. [Dopamine in cardiogenic shock]. Wujanz G Med Klin; 1976 Sep; 71(38):1534-8. PubMed ID: 979867 [No Abstract] [Full Text] [Related]
34. [Effects of dopamine on experimental cardiogenic shock]. Marchetti G; Merlo L; Noseda V Boll Soc Ital Cardiol; 1971; 16(10):615-9. PubMed ID: 5147986 [No Abstract] [Full Text] [Related]
35. [Mechanism of action of new sympathomimetics (dopamine and wyamine) and the ir therapeutic possibilities in cardiogenic shock]. Döring D Z Gesamte Inn Med; 1971 Jul; 26(13):Suppl:170-2. PubMed ID: 5125156 [No Abstract] [Full Text] [Related]
36. [Changes in some hemodynamic indices and the contractile state of the myocardium during infusion of dopamine in man]. Di Segni E; Capestro F; Curzi G; Di Luzio V; Purcaro A; Soro A; Di Giuseppe F Boll Soc Ital Cardiol; 1971; 16(10):611-4. PubMed ID: 5147985 [No Abstract] [Full Text] [Related]
37. [Studies on the therapy of shock in acute myocardial infarct]. Bravi A; Volpi G; Pupillo A; De Luca FM; Tuveri A Boll Soc Ital Cardiol; 1973; 18(2):139-46. PubMed ID: 4807052 [No Abstract] [Full Text] [Related]
38. [Pharmacotherapy of cardiogenic shock]. Ritz R Schweiz Med Wochenschr; 1988 Apr; 118(17):626-9. PubMed ID: 2898169 [TBL] [Abstract][Full Text] [Related]
39. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine. El Mokhtari NE; Arlt A; Meissner A; Lins M Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265 [TBL] [Abstract][Full Text] [Related]